Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 29, 2026	Mar. 30, 2025
Statement of Cash Flows [Abstract]
Cash and cash equivalents at beginning of period	$ 22,664	$ 26,805
Operating activities:
Net loss	(23,369)	(35,818)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
Equity in loss of unconsolidated affiliate	289	467
Depreciation and amortization expense	18,100	19,200
Non-cash compensation expense	2,431	2,442
Gain on foreign currency transaction, net	(1,775)
Gain on sale of assets	(308)	(4,296)
Deferred income taxes	231	563
Other, net	198	1,525
Changes in assets and liabilities:
Receivables, net	3,210	(1,757)
Inventories	21,185	(753)
Other current assets	2,089	(1,966)
Income taxes	5,409	(7,106)
Accounts payable and other current liabilities	(3,359)	2,020
Other, net	62	5,485
Net cash provided (used) by operating activities	24,393	(19,994)
Investing activities:
Capital expenditures	(3,872)	(7,915)
Proceeds from the sale of assets	501	8,094
Net cash (used) provided by investing activities	(3,371)	179
Financing activities:
Proceeds from ABL Revolver	81,500	167,150
Payments on ABL Revolver	(89,300)	(148,150)
Payments on ABL Term Loan	(6,900)	(6,900)
Payments on finance lease obligations	(2,412)	(2,397)
Other, net	(249)	(428)
Net cash (used) provided by financing activities	(17,361)	9,275
Effect of exchange rate changes on cash and cash equivalents	236	(10)
Net increase (decrease) in cash and cash equivalents	3,897	(10,550)
Cash and cash equivalents at end of period	$ 26,561	$ 16,255